MA09.03 Plasma Proteomics-based Models for Predicting Immunotherapy- and Chemotherapy-Related Toxicity in NSCLC Patients
Year: 2024
Type: conference-abstract
Source: Journal of Thoracic Oncology
Authors: J. Naidoo, D.R. Gandara, R.R. Sullivan, Y.K. Chae, D. Carbone, P. Christopoulos, N. Reinmuth, I. Koch, I. Puzanov, J. Bar, I. Kamer, M. Moskovitz, A. Levy-Barda, A. Agbarya, A. Zer, M. Gottfried, M. Abu Amna, S. Brown, M. Lotem, G. Price, A. Hassani, T. Harkovsky, R. Leibowitz, I. Sela, C. Lahav, B. Yellin, M. Harel, Y. Elon
Institutions: Royal College of Surgeons in Ireland, Beaumont Hospital, UC Davis Comprehensive Cancer Center, Massachusetts General Hospital, Northwestern Medicine, The Ohio State University, Roswell Park Comprehensive Cancer Center, Sheba Medical Center, Rabin Medical Center, Bnai Zion Medical Center, Rambam Health Care Campus, Meir Medical Center, Emek Medical Center, Cheltenham General Hospital, Hadassah Medical Center, Aberdeen Royal Infirmary, NHS Grampian
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W4403419995